Related Experiment Video
Updated: May 11, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors
1Laboratory of Cancer Biology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Old Road Campus, off Roosevelt Drive, Headington, Oxford, UK
Abstract:
Histone deacetylase (HDAC) is an emergent anticancer target, and HR23B is a biomarker for response to HDAC inhibitors. We show here that HR23B has impacts on two documented effects of HDAC inhibitors; HDAC inhibitors cause apoptosis in cells expressing high levels of HR23B, whereas in cells with low level expression, HDAC inhibitor treatment is frequently associated with autophagy. The mechanism responsible involves the interaction of HDAC6 with HR23B, which downregulates HR23B and thereby reduces the level of ubiquitinated substrates targeted to the proteasome, ultimately desensitising cells to apoptosis. Significantly, the ability of HDAC6 to downregulate HR23B occurs independently of its deacetylase activity. An analysis of the HDAC6 interactome identified HSP90 as a key effector of HDAC6 on HR23B levels. Our results define a regulatory mechanism that involves the interplay between HR23B and HDAC6 that influences the biological outcome of HDAC inhibitor treatment.
Insights
Histone deacetylase (HDAC) inhibitors affect cancer cell death pathways differently based on HR23B levels. HDAC6 interaction with HR23B, independent of its deacetylase activity, influences whether cells undergo apoptosis or autophagy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Histone deacetylase (HDAC) inhibitors are emerging anticancer agents.
- HR23B is a validated biomarker predicting response to HDAC inhibitors.
Purpose of the Study:
- To elucidate the mechanism by which HR23B influences HDAC inhibitor efficacy.
- To investigate the interplay between HDAC6, HR23B, and cellular response pathways.
Main Methods:
- Analysis of HDAC inhibitor effects on cells with varying HR23B expression levels.
- Investigation of the interaction between HDAC6 and HR23B.
- Proteomic analysis to identify HDAC6 interactors.
Main Results:
- HDAC inhibitors induce apoptosis in high HR23B-expressing cells and autophagy in low HR23B-expressing cells.
- HDAC6 directly downregulates HR23B levels, independent of its deacetylase activity.
- This downregulation reduces proteasomal degradation of ubiquitinated substrates, desensitizing cells to apoptosis.
- HSP90 was identified as a key mediator of HDAC6's effect on HR23B.
Conclusions:
- A novel regulatory mechanism involving HDAC6 and HR23B dictates the cellular response to HDAC inhibitors.
- This interplay influences whether cancer cells undergo apoptosis or autophagy, impacting therapeutic outcomes.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
09:14Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
Published on: January 14, 2016
Related Concept Videos
Homologous Recombination
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Hedgehog Signaling Pathway
Master Transcription Regulators
Co-activators and Co-repressors